Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Pharmacyclics total revenue for fourth quarter 2013 increases 113% to $123.6 million

Pharmacyclics, Inc. today reported financial results and recent developments for the quarter and year ended December 31, 2013.

20 Feb 2014

Predictors of bone metastasis, skeletal events in lung cancer identified

Researchers have identified a range of factors that are associated with the likelihood that a patient with advanced lung cancer will develop bone metastases or skeletal-related events.

20 Feb 2014

Researchers use cardiac monitor to assess atrial fibrillation after cryptogenic stroke

Larry Ambrose woke up one night, wandered into his kitchen but couldn't completely read the time on his microwave. A few days later when he noticed his blood pressure was unusually high, he went to the hospital and was diagnosed as having a stroke.

From Medtronic 20 Feb 2014

Lung cancer patients with Del19 mutation benefit most from afatinib

Afatinib has been approved in Germany since September 2013 for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with activating EGF receptor mutations who have not been treated with an EGF receptor tyrosine-kinase inhibitor (EGFR TKI).

20 Feb 2014

Bevacizumab offers no benefit for patients newly diagnosed with glioblastoma

Adding bevacizumab (Avastin) to standard chemotherapy and radiation treatment does not improve survival for patients newly diagnosed with the often deadly brain cancer glioblastoma, researchers report in the Feb. 20 issue of the New England Journal of Medicine.

20 Feb 2014

Certain fragments of DNA shed by tumors can be used to non-invasively screen for early-stage cancers

Certain fragments of DNA shed by tumors into the bloodstream can potentially be used to non-invasively screen for early-stage cancers, monitor responses to treatment and help explain why some cancers are resistant to therapies, according to results of an international study led by Johns Hopkins Kimmel Cancer Center investigators.

20 Feb 2014

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga® (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases.

20 Feb 2014

UPV/EHU researchers develop method for diagnosis, prognosis of cutaneous melanoma

UPV/EHU researchers have developed a method for the diagnosis and prognosis of cutaneous melanoma, the type of skin cancer with the highest mortality rate.This method will help not only in the more effective early detection of this cancer, but also in the development of more personalised treatments.

20 Feb 2014

New radiation-free MRI test effectively diagnoses cancer in children

A new type of whole-body magnetic resonance imaging test could be an alternative to standard positron emission tomography/computed tomography imaging for assessing cancer in children and young adults, but without exposure to radiation that has been shown to increase the risk of secondary cancers in later life.

20 Feb 2014

Accelovance opens new office in Research Triangle Park, North Carolina

Accelovance, a therapeutically focused clinical research organization (CRO), announced today the opening of a new office in Research Triangle Park (RTP), North Carolina.

20 Feb 2014

Vaccine-based clinical trial to improve survival outcomes of kidney cancer patients

The Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute has opened a novel Phase III, vaccine-based clinical trial aimed at providing kidney cancer patients long-term control of their disease.

20 Feb 2014

Breast cancer patients receiving radiotherapy show decreased fatigue as result of CBTH

Breast cancer patients receiving radiotherapy showed decreased fatigue as a result of cognitive behavioral therapy plus hypnosis (CBTH), according to a study recently published in the Journal of Clinical Oncology.

20 Feb 2014

Babies who develop leukemia appear to inherit strong genetic predisposition to disease

Babies who develop leukemia during the first year of life appear to inherit an unfortunate combination of genetic variations that can make the infants highly susceptible to the disease, according to a new study at Washington University School of Medicine in St. Louis and the University of Minnesota.

20 Feb 2014

Jubilant Biosys expands drug discovery alliance with Janssen Pharmaceutica

Jubilant Biosys, a Bengaluru based subsidiary of Jubilant Life Sciences, announced today that it has expanded its drug discovery alliance with Janssen Pharmaceutica N.V., Beerse, Belgium.

20 Feb 2014

New biologic drug to prevent growth of ovarian cancer cells

Researchers at Women & Infants Hospital of Rhode Island have developed a biologic drug that would prevent the production of a protein known to allow ovarian cancer cells to grow aggressively while being resistant to chemotherapy. This would improve treatment and survival rates for some women.

20 Feb 2014

iCAD total revenue for Q4 2013 increases 16.8% to $9.1 million

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three and twelve months ended December 31, 2013.

19 Feb 2014

Driver mutations found in more than half of adenosquamous lung carcinomas

Analysis of a large cohort of Chinese patients with adenosquamous lung carcinoma has identified known mutant kinases in more than half of the tumours, researchers report in the Journal of Thoracic Oncology.

19 Feb 2014

Nintedanib plus docetaxel shows second-line efficacy in recurrent NSCLC

Nintedanib plus docetaxel offers significant efficacy in patients with non-small-cell lung cancer who experience disease progression after first-line chemotherapy, phase III study results show.

19 Feb 2014

UH Case Medical Center cardiologists perform TAVR procedure under twilight

University Hospitals Case Medical Center cardiologists Marco Costa, MD, and Dan Simon, MD, are among the first in the country to perform transaortic valve replacements (TAVR) while the patient is in a "twilight" sedation, awake and communicating with them during the procedure.

19 Feb 2014

Researchers reveal effectiveness of web-based weight-loss programs

Researchers from The Miriam Hospital have found that DietBet, a web-based commercial weight loss program that pairs financial incentives with social influence, delivers significant weight losses. The study and its findings have been published in the current issue of the open access publication JMIR Serious Games.

19 Feb 2014

Oncology News and Research

Further Reading

Pharmacyclics total revenue for fourth quarter 2013 increases 113% to $123.6 million

Predictors of bone metastasis, skeletal events in lung cancer identified

Researchers use cardiac monitor to assess atrial fibrillation after cryptogenic stroke

Lung cancer patients with Del19 mutation benefit most from afatinib

Bevacizumab offers no benefit for patients newly diagnosed with glioblastoma

Certain fragments of DNA shed by tumors can be used to non-invasively screen for early-stage cancers

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

UPV/EHU researchers develop method for diagnosis, prognosis of cutaneous melanoma

New radiation-free MRI test effectively diagnoses cancer in children

Accelovance opens new office in Research Triangle Park, North Carolina

Vaccine-based clinical trial to improve survival outcomes of kidney cancer patients

Breast cancer patients receiving radiotherapy show decreased fatigue as result of CBTH

Babies who develop leukemia appear to inherit strong genetic predisposition to disease

Jubilant Biosys expands drug discovery alliance with Janssen Pharmaceutica

New biologic drug to prevent growth of ovarian cancer cells

iCAD total revenue for Q4 2013 increases 16.8% to $9.1 million

Driver mutations found in more than half of adenosquamous lung carcinomas

Nintedanib plus docetaxel shows second-line efficacy in recurrent NSCLC

UH Case Medical Center cardiologists perform TAVR procedure under twilight

Researchers reveal effectiveness of web-based weight-loss programs

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News